+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Computed Tomography (CT) Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 169 Pages
  • May 2023
  • Region: Global
  • GlobalData
  • ID: 5823067
The publisher's Medical Devices sector report, 'Computed Tomography (CT) Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Computed Tomography (CT) Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional image of an object from a flat X-ray image.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Computed Tomography (CT) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Computed Tomography (CT) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Computed Tomography (CT) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Computed Tomography (CT) Systems Overview
3 Products under Development
3.1 Computed Tomography (CT) Systems - Pipeline Products by Stage of Development
3.2 Computed Tomography (CT) Systems - Pipeline Products by Segment
3.3 Computed Tomography (CT) Systems - Pipeline Products by Territory
3.4 Computed Tomography (CT) Systems - Pipeline Products by Regulatory Path
3.5 Computed Tomography (CT) Systems - Pipeline Products by Estimated Approval Date
3.6 Computed Tomography (CT) Systems - Ongoing Clinical Trials
4 Computed Tomography (CT) Systems - Pipeline Products under Development by Companies
4.1 Computed Tomography (CT) Systems Companies - Pipeline Products by Stage of Development
4.2 Computed Tomography (CT) Systems - Pipeline Products by Stage of Development
5 Computed Tomography (CT) Systems Companies and Product Overview6 Computed Tomography (CT) Systems- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Computed Tomography (CT) Systems - Pipeline Products by Stage of Development
  • Computed Tomography (CT) Systems - Pipeline Products by Segment
  • Computed Tomography (CT) Systems - Pipeline Products by Territory
  • Computed Tomography (CT) Systems - Pipeline Products by Regulatory Path
  • Computed Tomography (CT) Systems - Pipeline Products by Estimated Approval Date
  • Computed Tomography (CT) Systems - Ongoing Clinical Trials
  • Computed Tomography (CT) Systems Companies - Pipeline Products by Stage of Development
  • Computed Tomography (CT) Systems - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Computed Tomography (CT) Systems - Pipeline Products by Stage of Development
  • Computed Tomography (CT) Systems - Pipeline Products by Segment
  • Computed Tomography (CT) Systems - Pipeline Products by Territory
  • Computed Tomography (CT) Systems - Pipeline Products by Regulatory Path
  • Computed Tomography (CT) Systems - Pipeline Products by Estimated Approval Date
  • Computed Tomography (CT) Systems - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Advanced Breast-CT GmbH
  • Annalise-AI Pty Ltd
  • Bioptics Technology LLC
  • California Institute of Technology
  • Canon Medical Systems Corp
  • Canon Medical Systems USA Inc
  • Duke University
  • Fermilab
  • FMI Medical Systems Inc
  • GE HealthCare Technologies Inc
  • German Cancer Research Center
  • Hitachi Medical Corp
  • Imatrex Inc
  • Izotropic Corp
  • Johns Hopkins University
  • Koning Corp
  • Koninklijke Philips NV
  • Malcova LLC
  • Massachusetts General Hospital
  • Micro-X Ltd
  • Nano Vision
  • Nanovision Technology Beijing Co Ltd
  • National Institutes of Health Clinical Center
  • NeuralRad LLC
  • Neusoft Medical Systems Co Ltd
  • Norsk Luftambulanse AS
  • Philips Healthcare
  • Shanghai United Imaging Healthcare Co Ltd
  • Siemens Healthineers AG
  • Stanford University
  • Stellarray, Inc.
  • TetraImaging LLC
  • The Hong Kong University of Science and Technology
  • The University of Manchester
  • Tribogenics, Inc.
  • United Imaging Systems (Beijing) Co Ltd
  • University Health Network
  • University of Antwerp
  • University of Auckland
  • University of California Santa Cruz
  • University of Louisville
  • University of Washington
  • Varex Imaging Corp
  • Varian Medical Systems Inc
  • Xoran Technologies LLC
  • ZumaTek, Inc.